• Explore /
  • Poster
  • / Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS).

Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS).

Abstract Poster

Authors

null

Myong Cheol Lim

Gynecologic Oncology, National Cancer Center Korea, Goyang-Si, Gyeonggi-do, South Korea

Myong Cheol Lim , Ji Hyun Kim , Boram Park , Jung-Yun Lee , Suk-Joon Chang , Yoo-Young Lee , Chel Hun Choi , Jeong-Yeol Park , Dae-Yeon Kim , Dae Gy Hong , Hyun-Woong Cho , Jae-Yun Song , Yun Hwan Kim , Ki Hyung Kim , Sang-Yoon Park , Seob Jeon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT05827523

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS5636)

DOI

10.1200/JCO.2024.42.16_suppl.TPS5636

Abstract #

TPS5636

Poster Bd #

499b

Abstract Disclosures

Similar Posters

First Author: Anne-Claire Hardy-Bessard

First Author: Thura Htut

First Author: Robert Hettle

Poster

2017 ASCO Annual Meeting

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

First Author: Willemien Van Driel